Table 2.
Baseline Laboratory Parameters and Chest CT of Patients With COVID‐19 With and Without NAFLD
| Variables (n [%] or Median [IQR]) | All Patients (N = 280) | Non‐NAFLD (n = 194) | NAFLD (n = 86) | P Value |
|---|---|---|---|---|
| WBC (×109/L) | 4.9 (3.9‐6.2) | 4.7 (3.7‐5.8) | 5.5 (4.2‐6.8) | <0.001 |
| Decreased | 71 (25.4) | 58 (29.9) | 13 (15.1) | 0.009 |
| Lymphocytes (×109/L) | 1.2 (0.9‐1.6) | 1.2 (0.9‐1.6) | 1.4 (0.9‐1.8) | 0.041 |
| Decreased | 75 (26.8) | 61 (31.4) | 14 (16.3) | 0.008 |
| ALT (U/L) | 25.0 (19.0‐37.0) | 23.0 (15.8‐30.0) | 34.5 (25.0‐50.5) | <0.001 |
| >40 U/L | 56 (20.0) | 21 (10.8) | 35 (40.7) | <0.001 |
| AST (U/L) | 24.8 (20.0‐32.0) | 24.0 (19.0‐32.0) | 26.0 (20.0‐33.3) | 0.222 |
| >40 U/L | 38 (13.6) | 24 (12.4) | 14 (16.3) | 0.378 |
| GGT (U/L) | 25.0 (15.0‐39.0) | 21.0 (14.0‐33.0) | 34.0 (19.8‐48.3) | <0.001 |
| >50 U/L | 42 (15.0) | 22 (11.3) | 20 (23.3) | 0.01 |
| Tbil (μmol/L) | 10.2 (7.1‐15.0) | 10.1 (7.0‐14.3) | 10.9 (7.8‐16.3) | 0.077 |
| >20 μmol/L | 26 (9.3) | 13 (6.7) | 13 (15.1) | 0.025 |
| ALP (U/L) | 63.0 (51.0‐75.0) | 62.0 (51.0‐77.0) | 63.0 (51.3‐72.8) | 0.617 |
| >150 U/L | 7 (2.5) | 7 (3.6) | 0 | 0.074 |
| FBG (mmol/L) | 5.7 (5.0‐6.4) | 5.6 (4.9‐6.2) | 5.7 (5.1‐7.0) | 0.116 |
| TG (mmol/L) | 1.2 (0.9‐1.6) | 1.1 (0.8‐1.5) | 1.4 (1.0‐1.9) | 0.004 |
| TC (mmol/L) | 3.8 (3.3‐4.5) | 3.7 (3.2‐4.4) | 3.9 (3.4‐4.6) | 0.078 |
| Chest CT | 0.727 | |||
| No pneumonia | 25 (8.9) | 19 (9.8) | 6 (7.0) | |
| Unilateral pneumonia | 37 (13.2) | 26 (13.4) | 11 (12.8) | |
| Bilateral pneumonia | 218 (77.9) | 149 (76.8) | 69 (80.2) |
Abbreviations: TC, total cholesterol; TG, triglyceride; WBC, white blood cells.